Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Dec 11, 2012 at 2:53 PM EST

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast.…

Jon C. Ogg | Dec 10, 2012 at 2:01 PM EST

J&J Gets Broader Use for Prostate Cancer Drug

ThinkstockJohnson & Johnson (NYSE: JNJ) may have an even larger winner with its prostate cancer drug called ZYTIGA. The Food…

Paul Ausick | Dec 7, 2012 at 9:21 AM EST

Amarin Takes on More Debt, Shares Suffer

ThinkstockBiopharmaceutical company Amarin Corp. PLC (NASDAQ: AMRN) announced after markets closed last night that it has received $100 million in…

Paul Ausick | Dec 4, 2012 at 9:03 AM EST

$4 Billion Deal in Medical Supplies Sector (BAX)

U.S. medical instruments and supplies maker Baxter International Inc. (NYSE: BAX) said this morning that it has signed a definitive…

Jon C. Ogg | Dec 3, 2012 at 4:19 PM EST

PDL BioPharma’s Questionable CFO Exit

PDL BioPharma Inc. (NASDAQ: PDLI) shareholders are going to be scratching their heads trying to figure out what is going…

Jon C. Ogg | Nov 28, 2012 at 10:49 AM EST

Analyst Sees 55% Upside in Small Biotech

ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was covered this morning in our analyst upgrades and downgrades daily summary, but call is worth…

Jon C. Ogg | Nov 27, 2012 at 3:15 PM EST

Merck Dividend Hike Likely to Pressure Pfizer

ThinkstockMerck & Co. (NYSE: MRK) has joined the dividend hike brigade. We were not sure if the pharmaceutical giant was…

Jon C. Ogg | Nov 27, 2012 at 8:58 AM EST

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

ThinkstockACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is proving to be the big winner of the day. In fact, it may be…

Paul Ausick | Nov 26, 2012 at 10:29 AM EST

UnitedHealth Forecast Disappoints

ThinkstockIn an announcement for its annual investor conference tomorrow, UnitedHealth Group Inc. (NYSE: UNH) reaffirmed its earnings per share (EPS)…

Paul Ausick | Nov 20, 2012 at 11:25 AM EST

Criminal Charges in Drug Insider Trading Scheme

ThinkstockThe U.S. Securities and Exchange Commission (SEC) today filed criminal charges against a former SAC Capital Advisors hedge-fund manager related…

Jon C. Ogg | Nov 16, 2012 at 8:48 AM EST

Death for Dynavax’s Lead Drug Candidate

ThinkstockDynavax Technologies Corp. (NASDAQ: DVAX) is feeling the wrath of the markets after an FDA panel said that there was…

Jon C. Ogg | Nov 12, 2012 at 9:03 AM EST

Gilead Sciences and Celgene Score Major Drug Wins

ThinkstockWhen biotech stocks become as big as some of the second-tier drug stocks, it represents billions of dollars worth of…

Trey Thoelcke | Nov 12, 2012 at 8:04 AM EST

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Paul Ausick | Nov 7, 2012 at 9:06 AM EST

Health Care Stocks Head in Different Directions (WLP, THC)

ThinkstockWellPoint Inc. (NYSE: WLP) and Tenet Healthcare Inc. (NYSE: THC) both reported third-quarter 2012 earnings this morning. WellPoint is health…

Jon C. Ogg | Nov 6, 2012 at 5:16 PM EST

Pfizer Scores FDA Approval on New Class of RA Drug … XELJANZ

Wikimedia CommonsPfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration approved its drug candidate called XELJANZ.…

1 … 310 311 312 313 314 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

J&J Gets Broader Use for Prostate Cancer Drug

Amarin Takes on More Debt, Shares Suffer

$4 Billion Deal in Medical Supplies Sector (BAX)

PDL BioPharma’s Questionable CFO Exit

Analyst Sees 55% Upside in Small Biotech

Merck Dividend Hike Likely to Pressure Pfizer

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

UnitedHealth Forecast Disappoints

Criminal Charges in Drug Insider Trading Scheme

Death for Dynavax’s Lead Drug Candidate

Gilead Sciences and Celgene Score Major Drug Wins

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Health Care Stocks Head in Different Directions (WLP, THC)

Pfizer Scores FDA Approval on New Class of RA Drug … XELJANZ

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

J&J Gets Broader Use for Prostate Cancer Drug

Amarin Takes on More Debt, Shares Suffer

$4 Billion Deal in Medical Supplies Sector (BAX)

PDL BioPharma’s Questionable CFO Exit

Analyst Sees 55% Upside in Small Biotech

Merck Dividend Hike Likely to Pressure Pfizer

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

UnitedHealth Forecast Disappoints

Criminal Charges in Drug Insider Trading Scheme

Death for Dynavax’s Lead Drug Candidate

Gilead Sciences and Celgene Score Major Drug Wins

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Health Care Stocks Head in Different Directions (WLP, THC)

Pfizer Scores FDA Approval on New Class of RA Drug … XELJANZ

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500